# Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

> **NCT01911728** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 14 (actual)

## Conditions studied

- Pharmacokinetics of MDV3100
- Castration Resistant Prostate Cancer (CRPC)

## Interventions

- **DRUG:** MDV3100
- **DRUG:** Pioglitazone
- **DRUG:** Warfarin
- **DRUG:** Omeprazole
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT01911728
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-25
- **Primary completion:** 2012-02-21
- **Final completion:** 2012-02-21
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01911728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01911728, "Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01911728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*